PL2817337T3 - Środki i sposoby pomiaru parathormonu u pacjentów cierpiących z powodu stresu oksydacyjnego - Google Patents

Środki i sposoby pomiaru parathormonu u pacjentów cierpiących z powodu stresu oksydacyjnego

Info

Publication number
PL2817337T3
PL2817337T3 PL13708713T PL13708713T PL2817337T3 PL 2817337 T3 PL2817337 T3 PL 2817337T3 PL 13708713 T PL13708713 T PL 13708713T PL 13708713 T PL13708713 T PL 13708713T PL 2817337 T3 PL2817337 T3 PL 2817337T3
Authority
PL
Poland
Prior art keywords
methods
oxidative stress
patients suffering
parathyroid hormone
measuring
Prior art date
Application number
PL13708713T
Other languages
English (en)
Inventor
Franz Paul Armbruster
Berthold Hocher
Hans Juergen Groen
Heinz Juergen ROTH
Original Assignee
Immundiagnostik Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immundiagnostik Ag filed Critical Immundiagnostik Ag
Publication of PL2817337T3 publication Critical patent/PL2817337T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/635Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/046Thyroid disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7004Stress
    • G01N2800/7009Oxidative stress

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL13708713T 2012-02-22 2013-02-22 Środki i sposoby pomiaru parathormonu u pacjentów cierpiących z powodu stresu oksydacyjnego PL2817337T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12156441.3A EP2631247A1 (en) 2012-02-22 2012-02-22 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
EP13708713.6A EP2817337B1 (en) 2012-02-22 2013-02-22 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
PCT/EP2013/053632 WO2013124462A1 (en) 2012-02-22 2013-02-22 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress

Publications (1)

Publication Number Publication Date
PL2817337T3 true PL2817337T3 (pl) 2019-06-28

Family

ID=47845933

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13708713T PL2817337T3 (pl) 2012-02-22 2013-02-22 Środki i sposoby pomiaru parathormonu u pacjentów cierpiących z powodu stresu oksydacyjnego

Country Status (8)

Country Link
US (1) US10317419B2 (pl)
EP (2) EP2631247A1 (pl)
JP (1) JP6178343B2 (pl)
CA (1) CA2865182C (pl)
ES (1) ES2716300T3 (pl)
PL (1) PL2817337T3 (pl)
TR (1) TR201902547T4 (pl)
WO (1) WO2013124462A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2775306B1 (en) * 2013-03-08 2018-06-27 Immundiagnostik AG Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients
CA2939366A1 (en) 2014-02-20 2015-08-27 Immundiagnostik Ag In vitro diagnostic and prognosis of contrast induced nephropathy (cin) in patients undergoing coronary angiography
EP3499235A1 (en) 2017-12-13 2019-06-19 Immundiagnostik AG Method of measuring auto-antibodies in bodily fluids
WO2019141791A1 (en) 2018-01-17 2019-07-25 Immundiagnostik Ag Biomarker predicting coronary artery disease
ES2984718T3 (es) 2018-08-20 2024-10-30 Immundiagnostik Ag Composición de sorbente para el tratamiento preanalítico de muestras
WO2025100417A1 (ja) * 2023-11-06 2025-05-15 株式会社ダイセル Aavのフルカプシドに対するアフィニティポリペプチド
CN120028422B (zh) * 2025-04-24 2025-08-22 东北师范大学 一种检测甲状旁腺激素的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006596A1 (en) 1987-03-02 1988-09-07 Bissendorf Peptide Gmbh New cardiodilatin fragment, process for preparing same and use thereof
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
DE4434551A1 (de) 1994-09-28 1996-04-04 Forssmann Wolf Georg Prof Dr D Peptide aus der Sequenz des hPTH (1-37)
DE19961350A1 (de) 1999-12-17 2001-06-21 Immundiagnostik Ag Verfahren zur Bestimmung der Parathormon-Aktivität in einer menschlichen Probe
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
DE10116552A1 (de) * 2001-04-03 2002-10-10 Abc Armbruster Biochemicals Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
US20030082179A1 (en) 2001-07-03 2003-05-01 Hutchison James Scott Parathyroid hormone antibodies and related methods
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
US7959920B2 (en) * 2005-09-06 2011-06-14 Scantibodies Laboratory, Inc. Methods of making and using antibodies directed to parathyroid hormone

Also Published As

Publication number Publication date
CA2865182C (en) 2020-08-25
JP6178343B2 (ja) 2017-08-09
CA2865182A1 (en) 2013-08-29
TR201902547T4 (tr) 2019-03-21
EP2631247A1 (en) 2013-08-28
JP2015513538A (ja) 2015-05-14
EP2817337B1 (en) 2018-12-19
EP2817337A1 (en) 2014-12-31
US10317419B2 (en) 2019-06-11
ES2716300T3 (es) 2019-06-11
WO2013124462A1 (en) 2013-08-29
US20150017738A1 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
ZA201400506B (en) Impedance measuring devices and methods for emergency cardiovascular care
EP2811897A4 (en) MEDICAL TERMINAL AND APPLICATION METHOD
IL237638B (en) Heteroaryl c17 derivatives of olanolic acid and methods of using them
IL237070A0 (en) Treatment of vaccine-related diseases and inflammatory diseases
GB201203005D0 (en) Medical apparatus and method
EP2891865A4 (en) MEASURING PROCESS AND MEASURING DEVICE
EP2715574A4 (en) METHOD AND APPARATUS FOR PROVIDING SUGGESTED TERMS
PL2817337T3 (pl) Środki i sposoby pomiaru parathormonu u pacjentów cierpiących z powodu stresu oksydacyjnego
GB2506503B (en) Infusion apparatus and method of use thereof
IL237656A0 (en) Blood coagulation meter and method
GB201214736D0 (en) Inflammation imaging and therapy
GB2499327B (en) Measurement apparatus and method
PL2861079T3 (pl) Sposób ważenia i urządzenie
EP2670438A4 (en) SELECTION AND TREATMENT OF PATIENTS
IL235865A0 (en) A motorized insole for lower limbs and a method for operating it
PL2644994T3 (pl) Sposób i urządzenie do utleniania pozostałości po spalaniu
GB2498453B (en) Current measuring device and method
EP2878943A4 (en) STRUCTURE WITH EMPTY SPACES AND MEASURING METHOD USING THE SAME
EP2843380A4 (en) METHOD FOR CHECKING THE WEIGHTING OF A MATERIAL AND ASSOCIATED DEVICE
IL239094A0 (en) Methods and devices for measuring relative critical dimensions
PL2940460T3 (pl) Urządzenie CT i jego sposób
GB2493595B (en) Wheelchair and method of construction
HUP1200081A2 (en) Quantitative in situ measurement of histone-dna interaction
GB201203663D0 (en) Note pad and method of use thereof
GB201200645D0 (en) Measuring apparatus and method